Biokinetica News Biokinetica’s Phase 1 Unit has been inspected twice by FDA!

Biokinetica’s Phase 1 Unit has been inspected twice by FDA!

We are pleased to inform you that Biokinetica’s Phase 1 Unit has recently undergone a FDA inspection on two of our biosimilar studies.

The results demonstrated GCP compliance, and our commitment towards the highest operative quality standards of our teams. We continually strive for excellence and efficiency to deliver quality services that are tailored to your needs.

Facebook
Twitter
LinkedIn
Email

To ensure the best possible experience, the website contains cookies. Please read our privacy policy.